Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
52-week open-label intramuscular depot aripiprazole maintenance study in bipolar I disorder
2012-004334-42Phase 3Completed
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization
- Start
- Dec 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of aripiprazole in bipolar I disorder, sponsored by Otsuka Pharmaceutical Development & Commercialization. Started Dec 2012; status: completed.
02
Drugs
aripiprazole
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on 2012-004334-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-004334-42.